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Summary.-An in vitro osteolysis assay with 45Ca-labelled mouse calvaria has been
used to investigate mechanisms of direct bone invasion by squamous carcinomas of
the head and neck. Short-term (3-day) organ cultures of 8 fresh squamous car-
cinomas showed varying degrees of in vitro bone-resorbing activity which was
blocked by indomethacin, an inhibitor ofprostaglandin synthesis. Supernatant media
from 6 established cell lines also induced bone resorption in vitro and evoked an
osteoclastic response in the cultured calvaria. Osteolysis by supernatant media was
not blocked by indomethacin in all the tumour-cell lines, and the production of non-
prostaglandin osteolysins by the indomethacin-resistant lines is postulated. The two
principal findings that emerge are: (1) Stimulants for osteoclastic activity are derived
from both squamous-carcinoma cells and from host cells in the tumour stroma.
(2) These stimulants are diverse. Indomethacin-sensitive agents, presumed to be
prostaglandins, are most convincingly demonstrated in the fresh tumours. Indo-
methacin-resistant agents, presumably not prostaglandins, are more characteristic
of the carcinoma cell lines.
SQUAMOUS CARCINOMAS of the head and
neck spread to bone by two routes. Blood-
borne metastases occasionally develop in
distant parts of the skeleton such as the
vertebrae, but morefrequently thetumours
invade contiguous bone a pattern of
spread that is uncommon in tumours at
most other sites. Those carcinomas of the
head and neck which, in surgical practice,
are most likely to invade local bone arise
in the oral cavity and paranasal sinuses;
carcinomas of the nasopharynx often
erode the skull base, but opportunities to
examine surgical material from such
tumours rarely arise.
The morphological process of direct
bone invasion by squamous carcinomas of
the head and neck involves 3 phases
(Carter et al., 1980; Carter & Pittam,
1980). The periosteum is first breached and
tumour cells infiltrate into the underlying
bone. There they evoke a striking increase
in local osteoclasts which erode bone
trabeculae in front of the advancing
tumour edge. The osteoclastic response
then subsides and squamous-carcinoma
cells, alone, continue to spread into the
bone. A similar sequence of events has
been described in relation to squamous
carcinomas invading metaplastic bone in
the ageing, focally ossified larynx (Carter
& Tanner, 1979).
The underlying mechanisms of the
osteolytic process are not clear, though
preliminaryinvestigations haveshownthat
freshly excised squamous carcinomas of
the head and neck contain extractable
prostaglandin (PG)-like materials (Bennett
et al., 1980) which, inter alia, activate
osteoclasts. The extracted material is pre-
dominantly of the PGE type, and appears
to be produced in the immediate vicinity
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ofthe tumour-probably from both carcin-
oma cells and host (stromal) cells. Further
work is now presented in which in vitro
bone resorption is examined in what are
essentially two complementary test sys-
tems: freshly excised squamous carcin-
omas, and established carcinoma-cell lines
which are free of host stromal elements.
The effects of indomethacin (an inhibitor
of PG synthesis) have also been investi-
gated, using the drug to separate out
indomethacin-sensitive osteolysins (i.e.
PGs) and indomethacin-resistant (i.e. non-
PG) factors.
MATERIALS AND METHODS
Bone resorption assay.-The methods used
are based on the procedure described by
Reynolds (1968). Two-3-day-old BALB/c
mice of either sex were each injected i.p.
with 45CaC12 (5 Ci in 0-05 ml 0.9% saline,
sp. act. 10-40 mCi/mg Ca; Radiochemical
Centre, Amersham). Three days later the
mice were anaesthetized with ether and their
calvaria dissected out aseptically and cul-
tured in modified Bigger's medium (Flow
Laboratories) for 24 h. The culture medium
was supplemented with 5%,/ heat-inactivated
rabbit serum (Gibco, Europe), antibiotics
(2.5 jg/ml fungizone, 100 jig/ml kanamycin),
fresh ascorbic acid (150 jg/ml) and L-
glutamine (200 jug/ml).
Paired half calvaria, mounted on stainless-
steel grids, were used for the resorption assays
-one half cultured with test medium or with
tumour fragments placed round the calvaria,
and one half with control medium. The test
media consisted of pH-adjusted supernatants
from carcinoma cell lines with or without
added indomethacin (see later); the control
media consisted of preincubated pH-adjusted
fresh culture medium. The bones were cul-
tured at 37°C in 500 CO2 in air for 3 days. The
pH of all culture media was measured at the
end of each assay. Release of 45Ca from the
isotopically labelled calvaria was estimated
by a liquid scintillation system (Packard
TRI-CARB model 2650). The percentage of
45Ca release from each bone was calculated
and the bone resorption activities expressed
as the ratio ofthe % of 45Ca release from the
test and control cultures. The values of each
bone-resorption ratio were recorded as the
mean + s.e. of 4 pairs of bone cultures.
Experiments to test the sensitivity of the
in vitro osteolysis assay showed measurable
release of 45Ca in response to the following
concentrations of added PGs (PGE2, 0-001-
0 01 g/ml; PGFir 0-1 jug/ml; PGF2o, 0-01
,Uo/ml) and bovine parathyroid hormone
(0001 u/ml) (Tsao, unpublishedobservations).
Freshly excised squamous carcinomas.-
Eight primary tumours were examined from
the following sites: oropharynx and pyriform
fossa 4, hypopharynx 1, tongue 1, floor of
mouth 1, nasal septum 1. Fragments of
tumour tissue were transferred in the oper-
ating theatre into cold sterile Medium 199
(Flow Laboratories) supplemented with 10%
foetal calf serum and antibiotics, and stored
temporarily at 4°C before the assays were
performed. The tissues were cut up into small
pieces , 1 mm3, weighed, washed with supple-
mented Medium 199, washed with supple-
mented Bigger's medium and set up in culture
in Bigger's medium containing 5% rabbit
serum. In each assay, 3 pieces of tumour
were placed round one half calvarium at a
distance of , 2 mm. Indomethacin (1 ,ug/ml)
was added to half the cultures. Control ex-
periments were set up with bone cultures
alone in medium, with and without indo-
methacin. After 3 days' culture, the pH of all
the culture media was measured and the
tumour fragments were processed routinely
for histology.
Squamous-carcinoma cell lines.-Six
tumour cell lines derived from squamous
carcinomas of the head and neck were ex-
amined. Details of the establishment and
properties of these and other squamous-
TABLE L.-Squamous-carcinoma cell lines,
LICR(Lond.)/HNI-6
LICR/HN
cell line*
1
2
3
4
5
6
Origint
M.51 Tongue
M.49 Larynx
M.63 Tongue
M.57 Larynx
M..73 Tongue
M.54Tongue
Months in
culture
33
28
27
29
12
12
* Nature of the cell lines confirmed by karyotype
analyses, ultrastructural appearances, and capacity
to grow as xenografts in immune-deprived CBA mice.
t M =male. Numbers represent age of patient. Specimens obtained at the time of radical surgery
(glossectomy and radical neck dissection, total
laryngectomy) for recurrent or radiation-resistant
primary tumours.
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carcinoma lines will be reported separately
(Easty et al., 1981) but their salient features
are shown in Table I.
The establishment of the carcinoma cell
lines may be briefly summarized as follows.
Fresh tumours were collected in theo perating
theatre and reduced to 2mm3 fragments.
Five to 6 fragments from each tumour were
then incubated for 5-7 days without disturb-
ance in 2-5ml Dulbecco's modified Eagle's
medium with 10% foetal calf serum (FCS) in
25cm2 flasks to permit attachment of ex-
plants. Fibroblasts were eliminated either by
mechanical scraping or with a complement-
dependent, cytotoxic monoclonal antifibro-
blast antibody (LICR LON/FIB 8b; Edwards
et al., 1980). Any residual normal epithelium
was lost through senescence and, in successful
cultures, a pure growth of proliferating
squamous-carcinoma cells remained which
could be serially subcultured.
For in vitro osteolysis assays, tumour cells
from the 6 lines were grown to confluence in
174cm2 culture flasks in Dulbecco's modified
Eagle's medium supplemented with 10%
FCS (Gibco, Europe) and antibiotics (100
,ug/ml benzyl penicillin, 2-5 ,ug/ml mino-
cycline) at 37°C in 10% CO2 in air. They were
then washed x 3 with Bigger's medium and
incubated with fresh Bigger's medium supple-
mented with 5% heat-inactivated rabbit
serum for 24 h. Cell-free supernatants, pre-
pared by Millipore filtration (0 45 rim), were
collected, pH-adjusted and assayed for osteo-
lytic activity. The remaining cell layers were
trypsinized and cell densities determined in
a haemacytometer cell. The pH of the test
and control media was measured at the end
of each 3-day assay.
The effects of indomethacin were studied
by including the drug (1 ,ug/ml) in the medium
for the initial 24h period of incubation of cell
cultures in modified Bigger's medium.
Three fibroblastoid cell lines derived from
primary cultures of squamous carcinomas
were also assayed for bone-resorbing activity.
Calvaria were examined histologically after
3 days' incubation in test and control cultures.
The specimens proved to be too fragile for
routine histological processing, but satis-
factory results were obtained with material
fixed in formol-saline, decalcified in EDTA,
embedded in methacrylate resin, cut at
1-2,m and stained with toluidine blue,
haematoxylin and eosin (HE) and methyl
green-pyronine (MGP).
RESULTS
In vitro osteolysis by fresh squamouis
carcinoma
The in vitro osteolytic activity of 8
primary squamous carcinomas is sum-
marized in Table II and Fig. 1. Four ofthe
TABLE II.-In vitro osteolysis byfresh squamous carcinomas
Site of
primary tumour
Pyriform fossa
Oropharynx
Tongue
Floor of mouth
Hypopharynx
Pyriform fossa
Nasal septum
Oropharynx
Amount 45Ca release
of tumour Indo- (test/control
(wet st. mg) methacin ratios)
113 - 2-49+0-23
113 + 1-91 + 0-13
- 2-01 + 0-06
+ 1-17+0-11
- 1-81 + 0:08
+ 1-30+ 0-10
75 - 1-69 + 0-22
74 + 1-48+0-15
- 1-30+ 0-13
+ 1-03+0-05
38 - 119+0-09
42 + 1-03 +0 03
53 - 1-16+0-09
46 + 1-05+0-07
74 - 1-12+0-03
73 + 1-10+0-04
ApH
0-08
0-08
0-02
0*05
0-17
0-24
0-11
0-10
-0-01
0-01
-0-03
-0 09
0-06
0*00
0 03
0-05
P*
<0-01
< 0 05
<0-01
< 0-01
< 0-01
< 0-01
< 0*05
N.S.
<0-02
N.S.
N.S.
N.S.
N.S.
N.S.
<0-01
N.S.
* Calculated according to Student's t test: significant level 0.05.
N.S. =not significant.
Patient
I1.
M.62
Conc.
F.54
Ahm.
F.58
Tsim.
M.65
Pat.
M.57
Hal.
M.63
Led.
M.64
Delv.
F.44
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FIG. 1. In vitro bone-resorbing activities of 8 freshly excised squamous carcinomas of the head
and neck with (stippled) or without (blank) 1 ,ug/ml indomethacin. There are 5 carcinomas of the
oropharynx (11, Conc., Pat., Hal., Delv.) and single examples of carcinomas of the tongue (Ahm.),
floor of mouth (Tsim.) and nasal septum (Led.). Each column represents the mean + s.e. osteolytic
activity of 4 pairs of test and control cultures.
tumours showed moderate to marked bone
resorption, measured by the release of
45Ca from isotopically labelled calvaria.
Osteolytic activity was less in all the
cultures to which the PG-synthesis in-
hibitor, indomethacin, was added; in 5 of
the tumours tested, this indomethacin-
associated decrease in bone resorption was
greater than 50%. Variations in pH of the
culture media in the course of the experi-
ments were small (see Table II).
The cultured tumour fragments were
well preserved and their histological
appearances were comparable to those of
the tumour in the main surgical specimens,
consisting of variable amounts of
squamous-carcinoma cells, fibrous stroma,
mixed inflammatory cells, granulation
tissue and necrotic debris (Fig. 2).
In vitro osteolysis by squamous-carcinoma
cell lines
Six established squamous-carcinoma
cell lines (LICR(Lond.)/HN1-6) were
examined. HN2 and 4 were derived from 2
TABLE III.-In vitro osteolysis
squamous-ccarcinoma cell lines
Cell
LICR/HN density
cell (x 105/
line ml)
4
M.57
Larynx
6
M.54
Tongue
2
M.49
Larynx
5
M.49
Tongue
M.51
Tongue
3
M.63
Tongue
FB 1
FB 2
FB 3
45Ca
release
(test/control) ApH
1-9 2-21 +0-10 - 0-02
2-9
3-4
2-2
1-87 + 0-14
2-02 + 0-22
1-76 + 009
9-5 1-50+0-08 -
11-5 1-55+0.09
2-6
3-3
3-2
1-28 + 0-08
1-59 + 0-07
1-54+ 0-13
1-9 1-35 + 0-14 -
1-9 1-52 + 0-13
by
p
<0-001
0-09 < 0-01
0 07 <0-01
0-14 <0.01
0-02 < 0-01
0-02 < 0-0l
0*05 < 0-02
0-15 < 0-01
0-11 <0-02
*0-3 N.S.
0-07 < 0-01
4-2 1-41 + 0-07 0-12 < 0-01
3-5 1-51 + 0 07 0-13 < 0-01
0S85+ 0 05 -0 05
2-7 1-07+0.09 0-06
2-2 1-61 +0-14 0.00
N.S.
N.S.
<0-02
.,L. V w
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Fie. 2. A,B. Fragments of two squamous carcinomas of the oropharynx after 3 days' culture.
The tumour cells are well preserved. Note the admixture of neoplastic and host stromal elements.
Both H. & E. x 200.
squamous carcinomas of the larynx, and
the remaining 4 lines from squamous
carcinomas of the tongue (see Table I).
The results of in vitro osteolysis assays,
using the supernatant culture media from
these 6 cell lines, are presented in Table III
and Fig. 3.
Supernatants from 2 of the cell lines-
HN4 and 6-produced marked bone re-
sorption. Culture media from the remain-
ing 4 cell lines were moderately active, as
were the media from one of the 3 control
fibroblastoid cell lines (Fig. 3). The results
of experiments with each cell line were
reproducible on 2 or 3 separate occasions.
Variations in pH of the culture medium in
the course of the assays were small (see
Table III).
Morphological changes were examined
in 4 pairs of test and control calvaria. The
slides were coded beforehand, but histo-
logical differences between the 2 groups
were readily apparent (Fig. 4). Bones
incubated for 3 days in control media
were smooth and the trabeculae appeared
intact. Multinucleate osteoclasts were in-
frequently seen. After incubation for 3
days with media from the carcinoma-cell
lines, the calvaria were soft and there was
obvious loss of bone substance. Multi-
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FIG. 3. In vitro bone-resorbing activities of supernatant media from 6 established squamous-
carcinoma cell lines: HNl, 3, 5 and 6-carcinomas of the tongue; HN2, 4-carcinomas of the
larynx. Media from 3 fibroblastoid cell lines (FB) are also included. Each column represents the
mean + s.e. osteolytic activities of 4 pairs of test and control cultures.
nucleate osteoclasts were conspicuous.
Several mononuclear cells which were not
osteoblasts were observed lying close to
the internal bone surfaces.
The effects of previous culture with
indomethacin on subsequent bone resorp-
tion were investigated in media from 4
squamous-carcinoma cell lines HN2, 3,
4 and 5. The results, shown in Table IV
and Fig. 5, differ from those described
earlier in relation to indomethacin and
fresh squamous carcinomas.
TABLE IV.-In vitro osteolysis by 4
squamous-carcinoma cell lines: effects of
indomethacin (1 igln/rl)
Cell
density Indo-
LICR/HN (x 105/ metha-
cell line ml) cin
HN4 19 - 2
2-3 + 2-
2-0 + 2-4
HN2 115 -
9.4 + l-'
HN5 3-2 -
3-4 + 1:
HN3 3.5 - l*
3-7 +
No differences in 45Ca relei
nificant.
45Ca
release
(test/
control)
21 +0-10
18+0 10
03+0-14
55+0 09
30+0 04
54+ 0-13
89 +0-05
51 +0 07
54+0 05
ApH
- 0-02
0-15
0 05
0-02
0 03
0-11
0-13
0-13
0-10
base statistically sig-
The effects of indomethacin varied in
different cell lines: in vitro bone resorption
was less in Lines HN4 and 2, unchanged in
HN3 and apparently greater in HN5. The
most obvious explanation for the failure
ofindomethacin to inhibit bone resorption
in this and in "indomethacin-resistant"
cultures is that the osteoclasts are stimu-
lated by factors other than PGs (see
Discussion).
DISCUSSION
Previous histological examination of
surgical specimens suggests that osteo-
clasts play an important role in the spread
of squamous carcinomas of the head and
neck into local bone (Carter et al., 1980;
Carter & Pittam, 1980; Carter & Tanner,
1979). These morphological features are
not specific, and the changes observed are
comparable to those associated with the
growth of blood-borne skeletal metastases
of various kinds (Galasko, 1975, 1976).
Similar findings have also been reported
in experimental tumours implanted in or
near bone (Faccini, 1974) though there is
controversy as to whether the morpho-
logical changes observed are confined to
I
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FIG. 4.-Fragments of neonatal mouse calvaria after 3 days' culture. A. Control calvarium. The bone
trabeculae are well preserved with no multinucleate osteoclasts. B. Test calvarium. The bone
substance is lost and multinucleate osteoclasts are prominent. Both H. & E. x 750.
the vicinity ofthe tumour (Galasko, 1976;
Galasko & Bennett, 1976; Young et al.,
1975; Hough et al., 1977; Wolfe et al.,
1978).
The present paper is concerned with
some of the mechanisms whereby osteo-
clasts in the vicinity of squamous carcin-
omas may be activated. A standard in
vitro bone-resorption assay has been used
(Reynolds, 1968) which provides repro-
ducible and accurate results. The short-
term organ cultures and the tumour-cell
lines provide complementary approaches
to the analysis of tumour-associated
osteolysis, but the two systems differ in
certain respects. The fragments of fresh
tumour presumably provide a continuous
source of osteolytic factors for most or all
of the 3 days that they are maintained in
culture. By contrast, bone-resorbing
activity released into the supernatant
medium by established tumour-cell lines
presumably ceases after the cells have
been removed by millipore filtration and
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FIG. 5. In vitro bone-resorbing activities
of supernatant media from 4 established
squamous-carcinoma cell lines, co-cultiva-
ted for 24 h with 1 mg/ml indomethacin
(stippled) or without (blank). Each column
represents the mean + s.e. osteolytic
activity of 4 pairs of test and control
cultures.
the assays set up with the cell-free super-
natants. The effects of indomethacin also
require careful interpretation. The drug
inhibits PG synthesis but it is not strictly
possible in our test systems to define the
source of any PGs produced. They can be
derived from the tumour cells or from the
bone itself in response to a variety of
agents as diverse as antibodies, proteo-
lytic enzymes and growth factors (Raisz
et al., 1974; Dowsett et al., 1976; Tashjian
& Levine, 1978).
Short-term (3-day) cultures of fresh
squamous carcinomas evoked a variable
degree of osteolysis; activity was marked
in 4 of the 8 tumours examined and, in all
of them, bone resorption was clearly
inhibited by indomethacin. These observa-
tions indicate that PGs are likely to be
involved, and the findings are compatible
with results from fresh squamous carcin-
omas of the head and neck (Bennett et al.,
1980). The evidence that PGs are released
in vitro and induce bone resorption is,
however, still indirect, and work is in
progress to separate and characterize
these indomethacin-sensitive factors. It is
also essential that bone resorption is
examined in more control tissues. The
choice of such material is difficult, and at
present we are collecting tissues from un-
involved resection lines from major sur-
gical specimens and from ostensibly nor-
mal tissues removed in the course ofdental
and plastic procedures. It is stressed that
the tumour fragments consist of a mixture
of neoplastic and stromal elements, and
that PGs and other "tumour-associated
products" may be derived from several
different cell types. Host cells, in this con-
text, may also include bone cells them-
selves which have been shown to elaborate
PGs-vide supra.
These non-homogeneous fragments of
fresh tumour correspond reasonably
closely to the carcinomas in the patients
from which they were obtained; but for a
closer analysis of bone destruction it is
necessary to examine the osteolytic capa-
city of carcinoma cells alone. These experi-
ments have now been done with a series of
squamous-carcinoma cell lines "uncon-
taminated" by host elements. Ten tumour
cell lines have been established by us
(Easty et al., 1981) and supernatant
culture media from 6 lines have been
assayed for osteolytic activity. A vari-
able degree of in vitro bone resorp-
tion was demonstrated. The effects of
indomethacin in this system were complex.
Instead of a uniform inhibition of osteo-
lysis, culture with indomethacin produced
a variety of effects, with bone resorption
decreased, unchanged or possibly, in one
line, enhanced. Previous work (Levine et
al., 1972; Dowsett et al., 1976) has shown
that indomethacin, tested at the same
concentration and for the same length of
time as in our own experiments, reduced
the in vitro production of PGs from high
levels to control values. More squamous-
carcinoma cell lines need to be examined,
but it is stressed that all lines with osteo-
lytic activity evoked an osteoclastic re-
sponse in the calvaria which were exposed
to their supernatant culture media. It
therefore appears that most of the lines so
far studied release indomethacin-resistant
(non-PG) factors. Various osteoclast-
activating factors other than PGs have
28
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been described but their identity and mode
of action remain unclear (Horton et al.,
1972; Mundy et al., 1974; Luben, 1980).
Some authors regard "osteoclast-activat-
ing factor" as a lymphokine, the secretion
ofwhich may be modified by PGs (Gordon
et al., 1976). Isolation and chemical
characterization of the indomethacin-
sensitive PGs associated with the carcin-
oma cell lines is in progress.
The local accumulation of osteoclasts
observed on the eroding bone surface in
surgical specimens is simulated in the test
calvaria maintained in vitro. Similar
accumulation in an in vitro system has
recently been reported by Schelling et al.
(1980). It is not clear whether osteoclasts
in these circumstances are redistributed or
increased in number (see Schelling et al.,
1980); accurate estimates of all the osteo-
lysing cells are, in our view, difficult to
make. Multinucleate osteoclasts can meas-
ure up to 80 ,um in diameter, and different
parts of the same cell may appear, dis-
continuously and cut obliquely, in differ-
ent parts of thin (1-2,tm) sections. In
addition, mononuclear cells can probably
also destroy bone (Mundy et al., 1977;
Kahn et al., 1978; McArthur et al., 1980).
Mononuclear cells were regularly seen by
us on the endosteal surfaces of resorbing
calvaria, but their identity, origin, and
function are obscure.
The work described here has concen-
trated solely on certain osteoclast-medi-
ated components of local bone destruction
associated with squamous carcinomas of
the head and neck. Lysosomal hydrolases
and other proteinases, tumour- or host-
cell-derived, which may be concerned with
the direct breakdown of the organic bone
matrix, have not been considered (Dowsett
et al., 1976; Eilon & Mundy, 1978;
Heersche, 1978). Two conclusions can be
drawn at this stage:
(1) Stimulants for osteoclastic activity
are derived from both carcinoma cells and
from host cells in the tumour stroma.
(2) These stimulants are diverse. Indo-
methacin-sensitive agents, presumed to be
PGs, are most convincingly demonstrated
in the fresh tumours. Indomethacin-
re8istant agents, presumed to be sub-
stances other than PGs, are more charac-
teristic ofthe homogeneous carcinoma cell
lines.
The clinical implications of PGs and
other products associated with squamous
carcinomas ofthe head and neck are being
followed. The short (3-day) cultures, in
particular, are comparatively simple to
handle and they provide results within a
week of surgery. It is improbable that
PGs and related substances will be useful
in specifically predicting bone invasion as
this can usually be assessed clinically, but
some other prognostic significance for
these products may become apparent (cf.
Fitzpatrick & Stringfellow, 1979; Rolland
et al., 1980).
We are indebted to Dr V. M. Dalley, Mr P.
Clifford, FRCS, and Mr H. J. Shaw, FRCS, for access
to clinical material; to Mr N. S. B. Tanner, FRCS,
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tumour tissue; to Mrs Diana Mitchell, Mr J. D. B.
Roberts and the staff of the histology laboratory;
and to Mr K. G. Moreman for preparing the illustra-
tions. S.W.T. is in receipt ofa Postgraduate Scholar-
ship awarded by the Shell Trading Company.
R.L.C. acknowledges financial support from the
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